| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 109 | 223 | 221 | 217 | 0 | 0 | 0 | - | 0 | 0 |
| Total Income - EUR | 109 | 223 | 221 | 217 | 0 | 0 | 0 | - | 0 | 0 |
| Total Expenses - EUR | 119 | 154 | 492 | 43 | 42 | 41 | 40 | - | 40 | 40 |
| Gross Profit/Loss - EUR | -10 | 69 | -271 | 174 | -42 | -41 | -40 | - | -40 | -40 |
| Net Profit/Loss - EUR | -13 | 62 | -278 | 167 | -42 | -41 | -40 | - | -40 | -40 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
Check the financial reports for the company - Vladmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Current Assets | 5.425 | 5.465 | 5.115 | 5.163 | 1.936 | 4.942 | 4.832 | - | 4.833 | 4.806 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Receivables | 4.999 | 4.897 | 4.785 | 4.656 | 1.936 | 4.454 | 4.356 | - | 4.356 | 4.331 |
| Cash | 426 | 569 | 330 | 507 | 0 | 487 | 477 | - | 477 | 474 |
| Shareholders Funds | -3.420 | -3.323 | -3.545 | -3.312 | 8 | -3.270 | -3.237 | - | -3.319 | -3.340 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | - | 40 | 40 |
| Debts | 8.846 | 8.789 | 8.660 | 8.475 | 1.927 | 8.211 | 8.070 | - | 8.151 | 8.146 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Vladmed S.r.l.